Worse Survival Observed Among Patients Diagnosed with Cancer During the First 2 Years of the COVID-19 Pandemic By Ogkologos - February 16, 2026 297 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the US cohort study Source RELATED ARTICLESMORE FROM AUTHOR Non-pharmacological interventions – are they important to patients with cancer? Two novel bispecific antibodies in combination with chemotherapy show efficacy in neuroendocrine carcinomas Sacituzumab tirumotecan plus pembrolizumab significantly prolongs progression-free survival in advanced non-small cell lung cancer MOST POPULAR What’s at the Root of Ovarian Cancer? New Study May Have... April 24, 2025 How can we improve LGBTQ+ cancer care? – That Cancer Conversation June 27, 2023 FDA Approvals Expand Initial Treatment Options for Multiple Myeloma January 7, 2025 EMA Recommends Extension of Indications for Cabozantinib July 10, 2025 Load more HOT NEWS COVID-19 Testing: What you need to know. Pembrolizumab Improves Survival in Advanced Triple-Negative Breast Cancer How My Stage 4 Esophageal Cancer Diagnosis Led Me to a... Adjuvant Imatinib Prolongs RFS and OS in Patients with Resected GIST...
